Outpatient Surgery Magazine

Special Outpatient Surgery Edition - Anesthesia - July 2017

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://outpatientsurgery.uberflip.com/i/841698

Contents of this Issue

Navigation

Page 30 of 54

J U LY 2 0 1 7 O U T P A T I E N TS U R G E R Y. N E T 3 1 needed to treat a stricken patient is roughly 2.2 to 2.5 mg/kilo. Ryanodex, the newest preparation, comes in 250 mg vials and can be dissolved with 5 to 10 ml of sterile water. Dantrium and Revonto come in 20 mg vials and require 60 ml of sterile water for reconstitution. That's a time-consuming process that requires quite a bit of manpower. Fewer vials of Ryanodex are needed to deliver the initial dose, but the agent is more expensive than the other options. Some facility leaders opt to stock the less expensive Dantrium and Revonto to safeguard against a rare event, and that's a rational argument, especially if your surgical team is big enough to reconstitute the formulations quickly and efficiently. Smaller outpatient centers with a limited amount of backup help might be better served with the more expensive Ryanodex, which can be mixed with less effort and in less time. Regardless of which dantrolene product you stock, make sure the supply is current and there's enough to administer the stabilizing or typical maximum dose: 36 vials of Dantrium or Revonto, or 3 vials of Ryanodex. 9. What else should I stock in my MH cart? Store sodium bicar- bonate, dextrose, calcium chloride or calcium gluconate, regular insulin and refrigerated cold saline solution for IV cooling. These drugs are used to treat the deadly consequences of MH, including high potassium levels that can stop the patient's heart. Also stock basic supplies such as syringes, IV catheters, nasogas- tric tubes and Toomey irrigation syringes. 10. How common is MH? Not very. The incidence of anesthetic-related episodes of MH is between 1 in 15,000 in children and 1 in 50,000 in adults, according to MHAUS. They're rare events, to be sure, but can occur in patients who are unaware of their susceptibility or who have been previously anesthetized without incident. OSM Dr. Watson (cbwmdct@aol.com) is an anesthesiologist at Bridgeport (Conn.) Hospital and a consultant for the Malignant Hyperthermia Association of the United States.

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - Special Outpatient Surgery Edition - Anesthesia - July 2017